Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Asano

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Mentorship to support career development among women physicians]Yoshiko Atsuta, Marie Ohbiki, Emiko Sakaida, et al.
The Journal of Antimicrobial Chemotherapy|March 23, 2006
Pharmacokinetics of ganciclovir in haematopoietic stem cell transplantation recipients with or without renal impairmentYuki Asano-Mori, Yoshinobu Kanda, Kumi Oshima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 17, 2015
[Subacute encephalopathy after high-dose methotrexate as prophylaxis for central nervous system relapse in a patient with intravascular large B-cell lymphoma]Mizuki Watanabe, Daisuke Kaji, Meiko Hashimoto-Maeda, et al.
Journal of Medical Virology|August 21, 2008
Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genesKumi Oshima, Yoshinobu Kanda, Shinichi Kako, et al.
Endocrine Journal|June 19, 2024
Improving glycemic control by transitioning from the MiniMed<sup>TM</sup> 640G to 770G in Japanese adults with type 1 diabetes mellitus: a prospective, single-center, observational studySatoshi Kubota, Ai Sato, Manami Hosokawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 3, 2024
[Fulminant Clostridioides difficile infection during treatment with FLT3 inhibitor for acute myeloid leukemia]Jotaro Yamamoto, Otoya Watanabe, Takashi Sako, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 21, 2024
Fatal outcome of BK virus encephalitis in an allogeneic stem cell transplantation recipientKyosuke Yamaguchi, Hisashi Yamamoto, Koji Izutsu, et al.
Annals of Hematology|May 12, 2012
Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS)Kumi Oshima, Wataru Takahashi, Yuki Asano-Mori, et al.
Cancer Medicine|May 27, 2022
Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphomaShinichi Makita, Go Yamamoto, Dai Maruyama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 2014
[Herpes simplex virus type 2 fulminant hepatitis after umbilical cord blood transplantation for acute myeloid leukemia]Mitsuhiro Yuasa, Kazuya Ishiwata, Takeshi Sugio, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Mentorship to support career development among women physicians]Yoshiko Atsuta, Marie Ohbiki, Emiko Sakaida, et al.
The Journal of Antimicrobial Chemotherapy|March 23, 2006
Pharmacokinetics of ganciclovir in haematopoietic stem cell transplantation recipients with or without renal impairmentYuki Asano-Mori, Yoshinobu Kanda, Kumi Oshima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 17, 2015
[Subacute encephalopathy after high-dose methotrexate as prophylaxis for central nervous system relapse in a patient with intravascular large B-cell lymphoma]Mizuki Watanabe, Daisuke Kaji, Meiko Hashimoto-Maeda, et al.
Journal of Medical Virology|August 21, 2008
Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genesKumi Oshima, Yoshinobu Kanda, Shinichi Kako, et al.
Endocrine Journal|June 19, 2024
Improving glycemic control by transitioning from the MiniMed<sup>TM</sup> 640G to 770G in Japanese adults with type 1 diabetes mellitus: a prospective, single-center, observational studySatoshi Kubota, Ai Sato, Manami Hosokawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 3, 2024
[Fulminant Clostridioides difficile infection during treatment with FLT3 inhibitor for acute myeloid leukemia]Jotaro Yamamoto, Otoya Watanabe, Takashi Sako, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 21, 2024
Fatal outcome of BK virus encephalitis in an allogeneic stem cell transplantation recipientKyosuke Yamaguchi, Hisashi Yamamoto, Koji Izutsu, et al.
Annals of Hematology|May 12, 2012
Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS)Kumi Oshima, Wataru Takahashi, Yuki Asano-Mori, et al.
Cancer Medicine|May 27, 2022
Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphomaShinichi Makita, Go Yamamoto, Dai Maruyama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 2014
[Herpes simplex virus type 2 fulminant hepatitis after umbilical cord blood transplantation for acute myeloid leukemia]Mitsuhiro Yuasa, Kazuya Ishiwata, Takeshi Sugio, et al.
Pageof 10